Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: World J Surg. 2016 Mar;40(3):706–714. doi: 10.1007/s00268-015-3307-y

Table 3.

Logistic regression analysis of factors associated with postoperative complication

Univariable analysis
Multivariable analysis
OR (95 % CI) P value OR (95 % CI) P value
Age 1.02 (1.00–1.03) 0.05 1.03 (0.99–1.06) 0.06
Male sex 0.77 (0.46–1.30) 0.33
Cardiac comorbidities 1.94 (0.89–4.21) 0.09
Chronic obstructive pulmonary disease 0.58 (0.20–1.66) 0.31
Liver disease 0.93 (0.66–1.30) 0.66
Diabetes mellitus 2.61 (1.32–5.05) 0.004 1.85 (0.75–4.62) 0.18
Incidental finding 0.87 (0.52–1.45) 0.59
Hormone secreting tumors 2.99 (1.74–5.11) <0.001 3.56 (1.65–7.69) 0.001
Right adrenal tumor 0.92 (0.55–1.52) 0.73
Capsular invasion 1.88 (1.01–3.52) 0.05 1.46 (0.66–3.21) 0.35
T stage
 I/II Ref
 III/IV 1.49 (0.88–2.51) 0.14
N stage
 N0 Ref
 N1 1.59 (0.64–3.96) 0.32
 Nx 0.94 (0.50–1.77) 0.86
Tumor size 1.01 (0.97–1.06) 0.63
Operation type
 Open abdominal or posterior Ref Ref
 Minimally invasive Surgery 0.57 (0.27–1.22) 0.15 0.47 (0.14–1.59) 0.23
 Thoraco-abdominal Surgery 2.59 (1.28–5.24) 0.008 2.85 (1.00–8.18) 0.05
Metastatic at time of presentation 1.61 (0.85–3.03) 0.14
Margin
 R0 Ref
 R1 1.91 (1.02–3.57) 0.04 1.17 (0.47–2.89) 0.73
 R2 2.26 (0.78–6.58) 0.13 1.38 (0.37–5.15) 0.63
Multi-organ resection 1.78 (1.07–2.97) 0.03 1.84 (0.75–4.62) 0.18
Neo-adjuvant chemotherapy 6.48 (0.71–58.86) 0.10